Boston’s XenoTherapeutics Prepares to Donate Xeno-Skin™ to Burn Victims of New Zealand

December 19, 2019

XenoTherapeutics, Inc. a clinical-stage biotechnology company focused on immunogenomic reprogramming of swine organs and tissues for human use, announced their readiness to supply victims of New Zealand’s White Island volcano tragedy with Xeno-Skin™, a live-cell product derived from genetically-engineered swine and cleared by the FDA for investigational use in human patients suffering severe and extensive burn wounds